Novonesis_Logo (1).png
Q3 update: Novonesis delivers strong Q3 results and now expects full-year organic sales growth at the upper end of 7-8%
November 07, 2024 02:02 ET | Novonesis (Novozymes A/S)
Following increasing demand in the first nine months of the 2024 financial year, Novonesis delivers 9% organic sales growth with a strong 11% organic sales growth in the third quarter. The strong...
Novonesis_Logo (1).png
Trading statement 9M 2024
November 07, 2024 01:59 ET | Novonesis (Novozymes A/S)
Organic pro forma sales growth of 9%, including 11% in the third quarter. Full-year organic sales growth outlook now expected at the upper end of the 7-8% range and the adjusted EBITDA margin...
Novonesis_Logo (1).png
Trading by management and close relations of management
November 04, 2024 07:21 ET | Novonesis (Novozymes A/S)
Announcement released on November 4, 2024 at 10:07:51 CET did not include PDF file. Please see the full announcement in the attached PDF file. Attachment ...
Novonesis_Logo (1).png
Trading by management and close relations of management
November 04, 2024 04:08 ET | Novonesis (Novozymes A/S)
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016,...
Novonesis_Logo (1).png
Major shareholder announcement
October 23, 2024 08:36 ET | Novonesis (Novozymes A/S)
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital...
Novonesis_Logo (1).png
New employee-elected board member
October 21, 2024 09:01 ET | Novonesis (Novozymes A/S)
Company announcement No. 42 Anne Breum, one of the employee-elected members of the Board of Directors of Novozymes A/S, part of Novonesis Group (the “Company”), has decided to step down as a board...
Novonesis_Logo (1).png
Trading by management and close relations of management
October 16, 2024 03:58 ET | Novonesis (Novozymes A/S)
Please see the attached PDF for details.      Trading by management and close relations of management In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse...
Novonesis_Logo (1).png
Major shareholder announcement
October 15, 2024 08:25 ET | Novonesis (Novozymes A/S)
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital...
Novonesis_Logo (1).png
Major shareholder announcement
October 09, 2024 04:37 ET | Novonesis (Novozymes A/S)
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital...
Novonesis_Logo (1).png
Major shareholder announcement
October 03, 2024 03:29 ET | Novonesis (Novozymes A/S)
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital...